Page 1 of Clinical Trials for Nordic Lymphoma Group [SPONSOR-COLLABORATORS], 9 Total Matches
- 1Active, not recruitingLast Updated: January 3, 2012Condition(s): Diffuse Large B-Cell Lymphoma
- 2RecruitingLast Updated: March 28, 2011Condition(s): Primary Disease
- 3Active, not recruitingLast Updated: November 2, 2010Condition(s): Lymphoma
- 4Active, not recruitingLast Updated: May 7, 2010Condition(s): Lymphoma
- 5RecruitingLast Updated: January 3, 2012Condition(s): Lymphoma, Mantle-Cell
- 6RecruitingImmunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOPLast Updated: May 4, 2012Condition(s): Peripheral T Cell Lymphoma, Unspecified; Angioimmunoblastic Lymphadenopathy; Extranodal NK/T-cell Lymphoma
- 7CompletedLast Updated: July 2, 2011Condition(s): Diffuse Large-Cell Lymphoma
- 8CompletedLast Updated: September 7, 2011Condition(s): Peripheral T-Cell Lymphoma
- 9SuspendedLast Updated: November 19, 2009Condition(s): Malignant Lymphoma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Nordic+Lymphoma+Group
